FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology. Invention represents RN2/14-human A(H6N2) strain actively propagating in developing chick embryos at the optimum temperature of 33 °C, which enables to accumulate viral material for further purification and concentration. Reassortant inherited a gene which codes the surface antigen of the haemagglutinin virus (HA) and six genes coding internal and non-structural proteins from A/17/silver gull/Sarma/06/887 (H6N1), and the gene coding the surface antigen of the virus neuraminidase (NA), from A/17/Hong Kong/2014/8296 (H3N2).
EFFECT: strain RN2/14-human A(H6N2) can be used for detecting antibodies to neuraminidase N2 of influenza virus in blood serum using solid-phase inhibition reaction of neuraminidase activity.
1 cl, 4 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| REASSORTANT INFLUENZA VIRUS STRAIN RN9/13-HUMAN A(H6N9) FOR NEURAMINIDASE ANTIBODY ASSAY IN INFLUENZA INFECTION AND VACCINATION | 2014 |
|
RU2587629C1 |
| REASSORTANT INFLUENZA VIRUS STRAIN A/17/SILVER GULL/SARMA/06/887 (H6N1) FOR PREPARING LIVE INFLUENZA VACCINE | 2015 |
|
RU2606026C1 |
| REASSORTANT STRAIN OF RN2/66-HUMAN A (H7N2) INFLUENZA VIRUS FOR NEURAMINIDASE ANTIBODIES IDENTIFICATION IN CASE OF INFLUENZA INFECTION AND VACCINATION | 2016 |
|
RU2625024C1 |
| REASSORTANT RN2/57-HUMAN A(H7N2) INFLUENZA VIRUS STRAIN FOR NEURAMINIDASE ANTIBODY ASSAY IN INFLUENZA INFECTION AND VACCINATION | 2011 |
|
RU2464312C1 |
| REASSORTANT RN A9-SWINE A(H7N1) INFLUENZA VIRUS STRAIN FOR NEURAMINIDASE ANTIBODY ASSAY IN INFLUENZA INFECTION AND VACCINATION | 2010 |
|
RU2428476C1 |
| INFLUENZA VIRUS STRAIN FOR PRODUCING LIVE AND INACTIVATED INFLUENZA VACCINE | 2011 |
|
RU2464309C1 |
| VACCINE INFLUENZA VIRUS STRAIN A/17/HONGKONG/2014/8296 (H3N2) FOR PREPARING LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2016 |
|
RU2606019C1 |
| STRAIN OF INFLUENZA VIRUS GKV 2389 FOR PRODUCTION OF LIVING INTRANASAL AND INACTIVATED INFLUENZA VACCINE | 2006 |
|
RU2318871C1 |
| VACCINE STRAIN OF INFLUENZA VIRUS A/17/HONGKONG/2017/75108 (H7N9) FOR PRODUCING POTENTIALLY PANDEMIC LIVE INTRANASAL INFLUENZA VACCINE | 2018 |
|
RU2685121C1 |
| REASSORTANT VACCINE STRAIN OF INFLUENZA A/17/DARWIN/2021/410 (H3N2) VIRUS FOR PRODUCTION OF LIVE INFLUENZA INTRANASAL VACCINE FOR ADULTS AND CHILDREN | 2023 |
|
RU2825673C1 |
